188 related articles for article (PubMed ID: 32407723)
1. CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain.
Bogacka J; Popiolek-Barczyk K; Pawlik K; Ciechanowska A; Makuch W; Rojewska E; Dobrogowski J; Przeklasa-Muszynska A; Mika J
Eur J Pharmacol; 2020 Aug; 880():173166. PubMed ID: 32407723
[TBL] [Abstract][Full Text] [Related]
2. CCR4 Antagonist (C021) Administration Diminishes Hypersensitivity and Enhances the Analgesic Potency of Morphine and Buprenorphine in a Mouse Model of Neuropathic Pain.
Bogacka J; Ciapała K; Pawlik K; Kwiatkowski K; Dobrogowski J; Przeklasa-Muszynska A; Mika J
Front Immunol; 2020; 11():1241. PubMed ID: 32760393
[TBL] [Abstract][Full Text] [Related]
3. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
Front Immunol; 2020; 11():615327. PubMed ID: 33408720
[TBL] [Abstract][Full Text] [Related]
4. The blockade of CC chemokine receptor type 1 influences the level of nociceptive factors and enhances opioid analgesic potency in a rat model of neuropathic pain.
Pawlik K; Piotrowska A; Kwiatkowski K; Ciapała K; Popiolek-Barczyk K; Makuch W; Mika J
Immunology; 2020 Apr; 159(4):413-428. PubMed ID: 31919846
[TBL] [Abstract][Full Text] [Related]
5. Blockade of CCR4 Diminishes Hypersensitivity and Enhances Opioid Analgesia - Evidence from a Mouse Model of Diabetic Neuropathy.
Bogacka J; Ciapała K; Pawlik K; Dobrogowski J; Przeklasa-Muszynska A; Mika J
Neuroscience; 2020 Aug; 441():77-92. PubMed ID: 32592824
[TBL] [Abstract][Full Text] [Related]
6. Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Jurga A; Slusarczyk J; Trojan E; Basta-Kaim A; Mika J
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():68-78. PubMed ID: 26190414
[TBL] [Abstract][Full Text] [Related]
7. Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain.
Pawlik K; Ciechanowska A; Ciapała K; Rojewska E; Makuch W; Mika J
Front Immunol; 2021; 12():781310. PubMed ID: 34795678
[TBL] [Abstract][Full Text] [Related]
8. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia.
Kwiatkowski K; Popiolek-Barczyk K; Piotrowska A; Rojewska E; Ciapała K; Makuch W; Mika J
Cytokine; 2019 Jul; 119():202-213. PubMed ID: 31003094
[TBL] [Abstract][Full Text] [Related]
9. The RS504393 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in Neuropathic Rats.
Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Mika J
J Neuroimmune Pharmacol; 2017 Sep; 12(3):402-419. PubMed ID: 28337574
[TBL] [Abstract][Full Text] [Related]
10. Metamizole relieves pain by influencing cytokine levels in dorsal root ganglia in a rat model of neuropathic pain.
Zajaczkowska R; Kwiatkowski K; Pawlik K; Piotrowska A; Rojewska E; Makuch W; Wordliczek J; Mika J
Pharmacol Rep; 2020 Oct; 72(5):1310-1322. PubMed ID: 32691345
[TBL] [Abstract][Full Text] [Related]
11. IL-1 receptor antagonist improves morphine and buprenorphine efficacy in a rat neuropathic pain model.
Pilat D; Rojewska E; Jurga AM; Piotrowska A; Makuch W; Przewlocka B; Mika J
Eur J Pharmacol; 2015 Oct; 764():240-248. PubMed ID: 26043968
[TBL] [Abstract][Full Text] [Related]
12. The role of keratinocyte-derived chemokine (KC) on hyperalgesia caused by peripheral nerve injury in mice.
Manjavachi MN; Costa R; Quintão NL; Calixto JB
Neuropharmacology; 2014 Apr; 79():17-27. PubMed ID: 24184386
[TBL] [Abstract][Full Text] [Related]
13. New insights into the analgesic properties of the XCL1/XCR1 and XCL1/ITGA9 axes modulation under neuropathic pain conditions - evidence from animal studies.
Ciechanowska A; Rojewska E; Piotrowska A; Barut J; Pawlik K; Ciapała K; Kreiner G; Mika J
Front Immunol; 2022; 13():1058204. PubMed ID: 36618360
[TBL] [Abstract][Full Text] [Related]
14. Respective pharmacological features of neuropathic-like pain evoked by intrathecal BDNF versus sciatic nerve ligation in rats.
M'Dahoma S; Barthélemy S; Tromilin C; Jeanson T; Viguier F; Michot B; Pezet S; Hamon M; Bourgoin S
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2118-30. PubMed ID: 26343858
[TBL] [Abstract][Full Text] [Related]
15. Tramadol has a better potency ratio relative to morphine in neuropathic than in nociceptive pain models.
Christoph T; Kögel B; Strassburger W; Schug SA
Drugs R D; 2007; 8(1):51-7. PubMed ID: 17249849
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury.
Piotrowska A; Rojewska E; Pawlik K; Kreiner G; Ciechanowska A; Makuch W; Nalepa I; Mika J
Front Immunol; 2019; 10():2198. PubMed ID: 31616413
[TBL] [Abstract][Full Text] [Related]
17. Early systemic granulocyte-colony stimulating factor treatment attenuates neuropathic pain after peripheral nerve injury.
Chao PK; Lu KT; Lee YL; Chen JC; Wang HL; Yang YL; Cheng MY; Liao MF; Ro LS
PLoS One; 2012; 7(8):e43680. PubMed ID: 22937076
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of intracellular signaling pathways NF-κB and MEK1/2 attenuates neuropathic pain development and enhances morphine analgesia.
Popiolek-Barczyk K; Makuch W; Rojewska E; Pilat D; Mika J
Pharmacol Rep; 2014 Oct; 66(5):845-51. PubMed ID: 25149989
[TBL] [Abstract][Full Text] [Related]
19. Zaprinast diminished pain and enhanced opioid analgesia in a rat neuropathic pain model.
Rojewska E; Piotrowska A; Jurga A; Makuch W; Mika J
Eur J Pharmacol; 2018 Nov; 839():21-32. PubMed ID: 30213497
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide from Rhodobacter sphaeroides (TLR4 antagonist) attenuates hypersensitivity and modulates nociceptive factors.
Jurga AM; Rojewska E; Makuch W; Mika J
Pharm Biol; 2018 Dec; 56(1):275-286. PubMed ID: 29656686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
